Speaker Profile
Carlo Ventura

Carlo Ventura MD, PhD

Molecular Biology, Biochemistry and Molecular Genetics
Bologna, Emilia-Romagna, Italy

Connect with the speaker?

Prof. Carlo Ventura was born on May 29, 1958. He received both his MD and Specialization in Cardiology from the School of Medicine of the University of Bologna, Italy. He obtained his Ph.D. in Biochemistry in 1990 from the University of Bologna. He was Researcher at the “Laboratory of Cardiovascular Science (L.C.S.)”, National Institute on Aging (N.I.A.) - National Institutes of Health (N.I.H.), Baltimore, MD, U.S.A. from 1988 to 1992. In the same laboratory he continued to perform repeated periods of research up to 1994. He has been Researcher (1990-2000), Associate Professor (2000) and then Full Professor of Biochemistry (2000-2003) at the Department of Biomedical Sciences of the University of Sassari, Italy.
Since November 28, 2003, he is Full Professor of Molecular Biology at the School of Medicine of the University of Bologna, Italy. He is Chief of the National Laboratory of Molecular Biology and Stem Cell Engineering of the National Institute of Biostructures and Biosystems, recently established at the Innovation Accelerators of CNR (National Research Council). He is also the Chief of the Division of Bologna of NIBB, including the NIBB Research Units of Bologna, Firenze, and Siena, Italy. In 2010, he founded VID art|science, a transdisciplinary movement of Artists and Scientists exploring the avant-garde of scientific innovation to unravel how Arts may talk to the innermost dynamics of our biology.
VID art and science is also dedicated to pursuing and promoting the evolving of a “Third Culture” by facilitating the infinite potential of collaborations between (media) Arts and Sciences. VID art andscience is working to help usher in a new culture that is overdue – a culture of creative thinkers from the Arts and Sciences who join together combining their knowledge and skills to come up with innovations, collaborations and most of all the development of novel paradigms.